Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Sekito

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Anticancer Research|August 30, 2023
Pre-operative Plasma Fibrinogen Level as a Potential Predictor of Pathological T3 Upstaging in Clinically Localized Renal Cell CarcinomaSho Sekito, Shiori Tanaka, Goshi Kitano, et al.
Clinical Genitourinary Cancer|January 11, 2025
Feasibility and Oncological Outcome of Patients Achieving Noninvasive Downstaging After Transurethral Resection of Bladder Tumor Plus Systemic Chemotherapy for Bladder Preservation Strategy in Muscle-Invasive Bladder CancerTakehisa Onishi, Takuji Shibahara, Sho Sekito, et al.
Indian Journal of Surgical Oncology|May 14, 2024
Predictive Factors for Extracapsular Extension of Prostate Cancer to Select the Candidates for Nerve-sparing Radical ProstatectomySho Sekito, Takehisa Onishi, Takashi Okamoto, et al.
Case Reports in Oncological Medicine|July 9, 2019
Successfully Treated Lung and Renal Metastases from Primary Chondrosarcoma of the Scapula with Radiofrequency Ablation and Surgical ResectionSho Sekito, Manabu Kato, Kouhei Nishikawa, et al.
IJU Case Reports|November 7, 2022
Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration-resistant prostate cancerTakumi Kageyama, Norihito Soga, Sho Sekito, et al.
Cancer Medicine|June 26, 2025
Narrative Review of Patient Cancer Tissue-Derived Zebrafish Xenograft Models for Evaluating Drug Sensitivity as an Avatar Model for Clinical ApplicationYusuke Sugino, Xin Bao, Takumi Kageyama, et al.
International Journal of Molecular Sciences|July 13, 2024
Purine-Rich Element Binding Protein Alpha, a Nuclear Matrix Protein, Has a Role in Prostate Cancer ProgressionTakahiro Inoue, Xin Bao, Takumi Kageyama, et al.
Cancer Science|July 24, 2025
Endothelial-Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate CancerTakumi Kageyama, Manabu Kato, Shiori Miyachi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 22, 2020
[LEIOMYOSARCOMA ARISING FROM THE RENAL VEIN]Sho Sekito, Kohei Nishikawa, Takumi Kageyama, et al.
Clinical Genitourinary Cancer|June 10, 2023
Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naïve Prostate Cancer PatientsTakeshi Sasaki, Toshifumi Takahashi, Sho Sekito, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Anticancer Research|August 30, 2023
Pre-operative Plasma Fibrinogen Level as a Potential Predictor of Pathological T3 Upstaging in Clinically Localized Renal Cell CarcinomaSho Sekito, Shiori Tanaka, Goshi Kitano, et al.
Clinical Genitourinary Cancer|January 11, 2025
Feasibility and Oncological Outcome of Patients Achieving Noninvasive Downstaging After Transurethral Resection of Bladder Tumor Plus Systemic Chemotherapy for Bladder Preservation Strategy in Muscle-Invasive Bladder CancerTakehisa Onishi, Takuji Shibahara, Sho Sekito, et al.
Indian Journal of Surgical Oncology|May 14, 2024
Predictive Factors for Extracapsular Extension of Prostate Cancer to Select the Candidates for Nerve-sparing Radical ProstatectomySho Sekito, Takehisa Onishi, Takashi Okamoto, et al.
Case Reports in Oncological Medicine|July 9, 2019
Successfully Treated Lung and Renal Metastases from Primary Chondrosarcoma of the Scapula with Radiofrequency Ablation and Surgical ResectionSho Sekito, Manabu Kato, Kouhei Nishikawa, et al.
IJU Case Reports|November 7, 2022
Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration-resistant prostate cancerTakumi Kageyama, Norihito Soga, Sho Sekito, et al.
Cancer Medicine|June 26, 2025
Narrative Review of Patient Cancer Tissue-Derived Zebrafish Xenograft Models for Evaluating Drug Sensitivity as an Avatar Model for Clinical ApplicationYusuke Sugino, Xin Bao, Takumi Kageyama, et al.
International Journal of Molecular Sciences|July 13, 2024
Purine-Rich Element Binding Protein Alpha, a Nuclear Matrix Protein, Has a Role in Prostate Cancer ProgressionTakahiro Inoue, Xin Bao, Takumi Kageyama, et al.
Cancer Science|July 24, 2025
Endothelial-Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate CancerTakumi Kageyama, Manabu Kato, Shiori Miyachi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 22, 2020
[LEIOMYOSARCOMA ARISING FROM THE RENAL VEIN]Sho Sekito, Kohei Nishikawa, Takumi Kageyama, et al.
Clinical Genitourinary Cancer|June 10, 2023
Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naïve Prostate Cancer PatientsTakeshi Sasaki, Toshifumi Takahashi, Sho Sekito, et al.
Pageof 4